Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne

Summary

The study was designed primarily to assess preliminary efficacy and safety of CJM112 in patients with moderate to severe inflammatory acne and to determine if CJM112 has an adequate clinical profile for further clinical development. In addition, sustainability of response and dose relationship were to be explored.

Timeline

Start

2016-12-22

Primary completion

2018-08-01

Completion

2018-08-01

Drugs

Indications